Specific selection of stimulation-responsive γδ T-cells utilizing a short-term activation assay

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• Gamma delta (γδ) T cells are a distinct subset of T lymphocytes, differing from alpha beta (αβ) T cells in antigen recognition.
• Unlike αβ T cells, γδ T cells are activated by non-peptide antigens independently of Major Histocompatibility Complex (MHC) presentation.
• γδ T cells, particularly Vδ2 T cells, exhibit intrinsic anti-tumor reactivity and are recognized as favorable prognostic markers in various cancers.

Purpose of the Study:

• To develop a method for identifying and isolating highly reactive γδ T cells for cancer immunotherapy.
• To investigate the potential of Vδ2 T cells in adoptive transfer therapies due to their MHC-independent activation and expansion capabilities.
• To adapt existing activation marker analysis for Vδ2 T cell characterization.

Main Methods:

• Analysis of γδ T cell activation using surface markers CD137 and CD154.
• Adaptation of CD137 and CD154 mobilization assays for Vδ2 T cell activation studies.
• Utilizing identified markers for cell sorting and subsequent expansion of specifically activated Vδ2 T cells.

Main Results:

• CD137 and CD154 were identified as suitable markers for detecting specifically activated γδ T cells.
• The method was successfully adapted for Vδ2 T cell activation analysis, enabling investigation of their responses.
• The markers CD137 and CD154 can be used to sort and expand specifically reacting Vδ2 T cells ex vivo.

Conclusions:

• A novel method enables rapid analysis of Vδ2 T cell activation.
• This approach facilitates the identification, isolation, and expansion of potent anti-tumor γδ T cells.
• The findings support the use of Vδ2 T cells in adoptive immunotherapy strategies for cancer treatment.